With more than 29 years in pharmaceuticals and 23 years focused on regulatory affairs, Wendy DeSpain offers deep experience in a variety of subject matter. Her responsibilities have included project management on regulatory-related activity and preparation of required submissions, including IND, NDA and BLA. She oversees ICON’s worldwide regulatory strategy efforts.